Excited and grateful to be part of this @novonordiskfond sponsored initiative to investigate if the gut microbiome causes cardiometabolic disease in humans!
By adding bacteria to our gut, removing them, or changing what we eat, we could reduce our risk of developing diseases such as obesity, type 2 diabetes, and cardiovascular disease.
A new research project, led by @foodDTUdk at @DTUtweet and funded by the Novo Nordisk Foundation, aims to find out more about this link, ultimately leading to new prevention or treatment options for people living with, or at risk of, cardiometabolic disease.
https://t.co/ml0STSSOqk
#obesity #diabetes #cardiovasculardisease
Great collaboration with @mfgrp from our @FondationLeducq transatlantic network spearheaded by Annika and Ariel now out in @NatureComms https://t.co/2MWXrf33yW
In collaboration with @DanielJDrucker we made the surprising observation 10+ years ago that GLP-1R deficient mice dies. Further work led by @GreinerTU with support from @MucinBiology revealed involvement of #gobletcells.
More essential roles for GLP-1R in the mouse gut, here in the maintenance of colonic physiology and survival during energy deprivation in germ free mice @BackhedLab@MolMetab https://t.co/w4nnMSrGP8
Ending the fall semester celebrating two excellent PhD defenses from Wilhelm Sjöland and Jamie Kraft @kraftyjamie . So proud of both of you - good luck with your future careers!
The second #TopGUTpaper from #Feb2023 is by Makki et al on
“6α-hydroxylated bile acids mediate TGR5 signalling to improve glucose metabolism upon dietary fiber supplementation in mice” via https://t.co/CGBLMGCMG2
Podcast: https://t.co/4FScL88scw
@BackhedLab